/THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES/
VANCOUVER, Dec. 20, 2018 /CNW/ - Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF) (the "Company" or "Koios"), a market leader in nootropic supplements and cannabis beverages, is pleased to announce the appointment of Andrew Fulton to the Company's Advisory Board.
Mr. Fulton has created and designed more than 30 award-winning products, the most recent of which is Colorado's Best Drinks, a full line of sparkling CBD sodas. Before that he co-founded Lifted Libations, a line of organic canned cocktails, and Rocky Mountain Soda in 2009, where he created and designed all 12 flavours and continues running the company today.
"Drew is a talented beverage maker who brings the added experience of success innovating in the CBD soda market," said Koios CEO Chris Miller. "That combined with his phenomenal acumen as an international business success has us all thrilled to have him join our board. We look forward to working together in the years to come."
Mr. Fulton studied international relations and diplomacy in China and continued his education at the London School of Economics. He also graduated Cum Laude from Schiller International University in Madrid, with an international business degree.
Upon moving back home to Denver, Mr. Fulton founded, built and orchestrated the buyout of numerous businesses, including in the transportation and finance sectors. He now concentrates mostly on the beverage sector, offering his consulting services to many name brand businesses around the world.
On behalf of the Board of Directors of the Company.
Chris Miller, CEO and Director, KOIOS BEVERAGE CORP.
About Koios Beverage Inc. The Company, through its wholly-owned subsidiary Koios, Inc., is an emerging functional beverage company which has an available distribution network of more than 2,000 retail locations across the United States in which to sell its products. Koios has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, Muscle Foods USA, KeHE, and Wishing-U-Well. Koios is also the sole owner of Cannavated Beverage Co., a subsidiary that develops beverage products and formulas for the growing cannabis market. Through its agreement with Keef Brands, the largest producer of cannabis beverages in North America, Cannavated enjoys distribution throughout the State of Colorado and is preparing for distribution in additional US states where cannabis use is legal.
Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants. Koios products can enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all day mental clarity. Its ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels and neural connections in the brain.
Koios is one of the only drinks in the world to infuse its products with MCT oil. MCT oil is derived from coconuts and has been shown to help the body burn fat more effectively, create lasting energy from a natural food source, produce ketones in the brain, allowing for greater brain function and clarity, support healthy hormone production and improve immunity. For more information, please visit our website: https://www.mentaltitan.com/
Forward-Looking Statements This news release contains forward-looking statements. All statements, other than statements of historical fact that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements in this news release include statements regarding the timing for resumption of trading for the Company's stock. The forward-looking statements reflect management's current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking statements. Although the Company believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, undue reliance should not be put on such statements due to their inherent uncertainty. Factors that could cause actual results or events to differ materially from current expectations include general market conditions and other factors beyond the control of the Company. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law. Koios has not conducted any scientific studies on the effects of Koios' products which have been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking Koios' products will vary from person to person. No claims or guarantees can be made as to the effects of Koios' products on an individual's health and wellbeing.